跳至主要内容
临床试验/NCT02298400
NCT02298400撤回不适用

A Single-Center, Cross-over, Pilot Study Evaluating Acuvue® Oasys® Lenses (Senofilcon A), 30-Day Bausch + Lomb PureVision (Balafilcon A), and Clariti® 1-Day (Somofilcon A) Lenses, for Their Impact on Ocular Discomfort Induced by Exposure to the Turbo Controlled Adverse Environment™

ORA, Inc.1 个研究点 分布在 1 个国家开始时间: 2014年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
Contact lens wear comfort, as assessed by subject reported symptoms in diaries.

研究概览

简要总结

The purpose of this study is to compare the comfort of three commercially available contact lenses.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Be at least 18 years old
  • •Have provided written informed consent
  • •Have discomfort when wearing contact lenses

排除标准

  • •Have an active ocular infection or significant slit lamp findings
  • •Participated in any other studies in the past 30 days

研究组 & 干预措施

Clariti® 1-Day (Somofilcon A)

Active Comparator

Clariti® 1-Day (Somofilcon A) contact lenses

干预措施: 30-Day Bausch + Lomb PureVision (balafilcon A) (Device)

Acuvue®Oasys® Lenses(senofilcon A)

Active Comparator

Acuvue® Oasys® Lenses (senofilcon A) contact lenses

干预措施: Acuvue® Oasys® Lenses (senofilcon A) (Device)

Acuvue®Oasys® Lenses(senofilcon A)

Active Comparator

Acuvue® Oasys® Lenses (senofilcon A) contact lenses

干预措施: 30-Day Bausch + Lomb PureVision (balafilcon A) (Device)

Acuvue®Oasys® Lenses(senofilcon A)

Active Comparator

Acuvue® Oasys® Lenses (senofilcon A) contact lenses

干预措施: Clariti® 1-Day (Somofilcon A) (Device)

Bausch + Lomb PureVision (balafilcon A)

Active Comparator

30-Day Bausch + Lomb PureVision (balafilcon A) contact lenses

干预措施: Acuvue® Oasys® Lenses (senofilcon A) (Device)

Bausch + Lomb PureVision (balafilcon A)

Active Comparator

30-Day Bausch + Lomb PureVision (balafilcon A) contact lenses

干预措施: 30-Day Bausch + Lomb PureVision (balafilcon A) (Device)

Bausch + Lomb PureVision (balafilcon A)

Active Comparator

30-Day Bausch + Lomb PureVision (balafilcon A) contact lenses

干预措施: Clariti® 1-Day (Somofilcon A) (Device)

Clariti® 1-Day (Somofilcon A)

Active Comparator

Clariti® 1-Day (Somofilcon A) contact lenses

干预措施: Acuvue® Oasys® Lenses (senofilcon A) (Device)

Clariti® 1-Day (Somofilcon A)

Active Comparator

Clariti® 1-Day (Somofilcon A) contact lenses

干预措施: Clariti® 1-Day (Somofilcon A) (Device)

结局指标

主要结局

Contact lens wear comfort, as assessed by subject reported symptoms in diaries.

时间窗: 1 week

次要结局

未报告次要终点

研究者

发起方
ORA, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验